Advertisement

TMSL - ETF AI Analysis

Compare

Top Page

TMSL

T. Rowe Price Small-Mid Cap ETF (TMSL)

Rating:68Neutral
Price Target:
$38.00
The T. Rowe Price Small-Mid Cap ETF (TMSL) demonstrates solid overall quality, driven by strong contributions from holdings like TechnipFMC and Rambus. TechnipFMC benefits from robust financial performance and positive earnings sentiment, while Rambus adds strength with high profitability and revenue growth. However, weaker holdings such as Insmed, which struggles with profitability and cash flow issues, slightly dampen the fund's rating. A key risk factor is the ETF's exposure to stocks with valuation concerns, which could impact future performance.
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Rambus and InterDigital, have delivered strong year-to-date performance, supporting overall fund returns.
Sector Diversification
The ETF spreads its investments across multiple sectors, including Technology, Industrials, and Health Care, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The fund has shown solid year-to-date growth, indicating strong momentum in its portfolio.
Negative Factors
High Geographic Concentration
With over 99% of its holdings in U.S. companies, the ETF lacks exposure to international markets, limiting diversification.
Underperforming Holdings
Some top holdings, such as Corpay Inc and Renaissancere Holdings, have struggled with weak or negative year-to-date performance, dragging on overall returns.
Moderate Expense Ratio
The ETF’s expense ratio is higher than some low-cost alternatives, which could eat into long-term returns.

TMSL vs. SPDR S&P 500 ETF (SPY)

TMSL Summary

The T. Rowe Price Small-Mid Cap ETF (TMSL) focuses on small to mid-sized companies in the U.S., offering exposure to businesses that are often innovative and growing but not as prominent as large-cap companies. It includes a diverse range of industries like technology, healthcare, and financials, with top holdings such as MKS and Tenet Healthcare. This ETF is a great choice for investors looking to diversify their portfolio and potentially benefit from the growth of emerging companies. However, it’s important to note that small and mid-sized companies can be more volatile, meaning their stock prices may rise and fall more sharply than larger, established firms.
How much will it cost me?The T. Rowe Price Small-Mid Cap ETF (TMSL) has an expense ratio of 0.55%, which means you’ll pay $5.50 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers select investments rather than tracking a passive index.
What would affect this ETF?The T. Rowe Price Small-Mid Cap ETF (TMSL) could benefit from economic growth and innovation in sectors like technology and health care, which are heavily represented in its holdings. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact smaller companies and more volatile industries such as consumer cyclical and financials. Additionally, its U.S.-focused exposure makes it sensitive to domestic regulatory changes and market conditions.

TMSL Top 10 Holdings

The T. Rowe Price Small-Mid Cap ETF (TMSL) leans heavily into technology and industrials, with names like Rambus and MKS Instruments driving recent gains thanks to strong financial performance and innovation in AI and data centers. Healthcare stocks like Tenet Healthcare are steady contributors, while financials such as Popular show mixed momentum despite solid fundamentals. On the downside, Corpay Inc has been lagging, holding back the fund’s progress. With a U.S.-focused portfolio, this ETF captures the energy of emerging businesses, though its reliance on a few sectors adds a layer of concentration risk.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
MKS1.27%$13.24M$9.59B31.09%
74
Outperform
Renaissancere Holdings1.16%$12.17M$12.15B0.48%
78
Outperform
Tenet Healthcare1.15%$12.05M$16.95B25.38%
73
Outperform
APi Group1.11%$11.62M$15.68B57.10%
74
Outperform
Popular1.11%$11.56M$7.70B14.91%
70
Outperform
TechnipFMC1.05%$10.96M$17.67B49.88%
80
Outperform
Rambus0.99%$10.40M$10.25B73.28%
78
Outperform
Insmed0.97%$10.17M$41.21B196.35%
53
Neutral
Western Alliance0.94%$9.81M$8.60B-17.26%
69
Neutral
Corpay Inc0.94%$9.79M$19.52B-24.79%
73
Outperform

TMSL Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
35.06
Negative
100DMA
34.39
Negative
200DMA
32.80
Positive
Market Momentum
MACD
-0.20
Positive
RSI
36.58
Neutral
STOCH
19.18
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TMSL, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 35.05, equal to the 50-day MA of 35.06, and equal to the 200-day MA of 32.80, indicating a neutral trend. The MACD of -0.20 indicates Positive momentum. The RSI at 36.58 is Neutral, neither overbought nor oversold. The STOCH value of 19.18 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TMSL.

TMSL Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.03B0.55%
68
Neutral
$9.99B0.21%
73
Outperform
$9.99B0.15%
74
Outperform
$9.93B0.12%
74
Outperform
$2.03B0.24%
67
Neutral
$1.12B0.60%
72
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TMSL
T. Rowe Price Small-Mid Cap ETF
34.01
0.66
1.98%
DUHP
Dimensional US High Profitability ETF
AVUS
Avantis U.S. Equity ETF
DFAU
Dimensional US Core Equity Market ETF
JMEE
JPMorgan Market Expansion Enhanced Equity ETF
SMIG
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement